James Wilding

James’ practice focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector. He also has extensive experience with supplementary protection certificates (SPCs) and has prosecuted SPC applications covering a number of blockbuster drugs. · Mathys & Squire LLP

EnglandIntellectual Property, Patent Prosecution & Opposition

E-mail Appeler

À propos

James focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector and has extensive experience with supplementary protection certificates (SPCs), including prosecuting SPC portfolios and advising on SPC disputes. He regularly appears before EPO tribunals on behalf of clients and coordinates SPC/paediatric extension portfolios across Europe.

Domaines d’expertise

Intellectual PropertyPatent Prosecution & OppositionLife SciencesPharmaceuticalsBiotechnologySupplementary Protection Certificates (SPCs)

Bureau

England

Mathys & Squire LLP · James’ practice focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector. He also has extensive experience with supplementary protection certificates (SPCs) and has prosecuted SPC applications covering a number of blockbuster drugs.

England

Expertise

ImmunologyAntibody-based therapeuticsVaccinesDiagnosticsNucleic acid amplificationOligonucleotide therapyGene editingPlant extractsSupplementary Protection Certificates (SPCs)EPO opposition proceedingsPaediatric extensions/SPC portfolios

Formation

Master’s degree in Biochemistry, Oxford University
Doctorate in the biochemistry of heart disease, Oxford University
Post-doctoral research on cardiac disease, Université Paris-XI

Inscriptions au barreau

Fellow of the Chartered Institute of Patent Attorneys (CIPA)
Member of the European Patent Institute (EPI)